bleuacacia (BLEUW) Competitors $0.0099 0.00 (0.00%) (As of 11/14/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends BLEUW vs. AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, AITRR, AFJKR, and AIMBUShould you be buying bleuacacia stock or one of its competitors? The main competitors of bleuacacia include AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), AI Transportation Acquisition (AITRR), Aimei Health Technology (AFJKR), and Aimfinity Investment Corp. I (AIMBU). These companies are all part of the "trading" industry. bleuacacia vs. AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition AI Transportation Acquisition Aimei Health Technology Aimfinity Investment Corp. I bleuacacia (NASDAQ:BLEUW) and AGBA Group (NASDAQ:AGBAW) are both financial services companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Does the media prefer BLEUW or AGBAW? In the previous week, bleuacacia had 1 more articles in the media than AGBA Group. MarketBeat recorded 1 mentions for bleuacacia and 0 mentions for AGBA Group. bleuacacia's average media sentiment score of 1.89 beat AGBA Group's score of 0.00 indicating that bleuacacia is being referred to more favorably in the media. Company Overall Sentiment bleuacacia Very Positive AGBA Group Neutral Is BLEUW or AGBAW more profitable? Company Net Margins Return on Equity Return on Assets bleuacaciaN/A N/A N/A AGBA Group N/A N/A N/A Does the MarketBeat Community favor BLEUW or AGBAW? bleuacacia and AGBA Group both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformbleuacaciaN/AN/AAGBA GroupN/AN/A Which has higher earnings and valuation, BLEUW or AGBAW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobleuacaciaN/AN/AN/AN/AN/AAGBA Group$38.55MN/AN/AN/AN/A Summarybleuacacia beats AGBA Group on 2 of the 3 factors compared between the two stocks. Ad Porter & CompanyFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Get bleuacacia News Delivered to You Automatically Sign up to receive the latest news and ratings for BLEUW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLEUW vs. The Competition Export to ExcelMetricbleuacaciaShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$47.69M$3.30B$8.88BDividend YieldN/A5.53%4.59%4.03%P/E RatioN/A32.25433.8517.46Price / SalesN/A975.673,432.1692.75Price / CashN/A91.0549.4236.42Price / BookN/A4.341.505.86Net IncomeN/A-$2.24M$399.06M$225.15M7 Day PerformanceN/A1.89%0.48%-0.90%1 Month PerformanceN/A2.39%0.75%3.70%1 Year PerformanceN/A0.83%17.39%26.40% bleuacacia Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLEUWbleuacaciaN/A$0.01flatN/A+11.0%$0.00N/A0.004Positive NewsGap UpAGBAWAGBA GroupN/A$0.21+10.3%N/A+545.2%$0.00$38.55M0.00152Gap UpAGNCPAGNC InvestmentN/A$24.96+0.4%N/A+20.0%$0.00$1.26B0.0050Short Interest ↑Positive NewsAGNCOAGNC InvestmentN/A$25.33+0.2%N/A+13.1%$0.00$1.26B0.0050Short Interest ↑AGNCNAGNC InvestmentN/A$25.65+0.0%N/A+2.6%$0.00$1.26B0.0050Short Interest ↑AGNCMAGNC InvestmentN/A$25.07-0.2%N/A+9.7%$0.00$1.26B0.0050News CoveragePositive NewsAGNCLAGNC InvestmentN/A$25.27+0.1%N/A+22.2%$0.00$1.26B0.0050Short Interest ↓Positive NewsANSCWAgriculture & Natural Solutions AcquisitionN/A$0.27flatN/AN/A$0.00N/A0.00N/APositive NewsAITRRAI Transportation AcquisitionN/A$0.11flatN/AN/A$0.00N/A0.00N/APositive NewsAFJKRAimei Health TechnologyN/A$0.23flatN/AN/A$0.00N/A0.00N/APositive NewsAIMBUAimfinity Investment Corp. IN/A$11.64+0.3%N/A+8.3%$0.00N/A0.002Positive News Related Companies and Tools Related Companies AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors AI Transportation Acquisition Competitors Aimei Health Technology Competitors Aimfinity Investment Corp. I Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BLEUW) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bleuacacia ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share bleuacacia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
